XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Cash flows from operating activities    
Net loss $ (156,811) $ (193,237)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Allowance for expected credit losses 1,592 1,025
Depreciation and amortization 15,918 12,730
Amortization of deferred contract acquisition costs 20,805 19,189
Stock-based compensation expense 165,067 160,702
Net accretion of discount on marketable securities (1,717) (4,646)
Non-cash lease expense 13,688 13,528
Impairment of long-lived assets 30,716 0
Amortization of discount on revolving credit facility and term loan issuance costs 91 91
Changes in operating assets and liabilities:    
Accounts receivable 14,376 20,610
Prepaid expenses and other current assets (24,711) (15,852)
Other assets 561 (4,594)
Accounts payable 2,609 4,610
Accrued expenses and other liabilities (4,836) (11,408)
Deferred revenue 2,326 10,920
Operating lease liabilities (16,903) (14,598)
Net cash provided by (used in) operating activities 62,771 (930)
Cash flows from investing activities    
Purchases of marketable securities (161,077) (166,628)
Maturities of marketable securities 165,576 195,605
Purchases of property and equipment (2,604) (4,064)
Capitalized internal-use software costs (7,361) (4,702)
Net cash (used in) provided by investing activities (5,466) 20,211
Cash flows from financing activities    
Repayment of term loan (3,750) (1,875)
Repurchases of common stock (74,183) (73,869)
Proceeds from exercise of stock options 2,835 3,884
Proceeds from employee stock purchase plan 13,012 13,665
Taxes paid related to net share settlement of equity awards 0 (5)
Net cash used in financing activities (62,086) (58,200)
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash 3,795 (656)
Net decrease in cash, cash equivalents, and restricted cash (986) (39,575)
Cash, cash equivalents, and restricted cash    
Beginning of period 184,864 236,663
End of period 183,878 197,088
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 183,470 196,772
Restricted cash 408 316
Total cash, cash equivalents, and restricted cash 183,878 197,088
Supplemental cash flow data    
Cash paid for income taxes 2,904 3,776
Supplemental non-cash investing and financing information    
Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities 835 1,193
Stock-based compensation expense capitalized for internal-use software 5,243 3,299
Repurchases of common stock in accrued expenses and other current liabilities $ 0 $ 820